#Industry News
Transarterial Chemoembolization(TACE)
Model:Peripheral Vascular
Transarterial Chemoembolization (TACE) is a minimally invasive procedure used in the treatment of liver cancer, specifically hepatocellular carcinoma (HCC). This technique combines the localized delivery of chemotherapy drugs with the arterial embolization of the blood vessels supplying the tumor, offering a targeted approach to cancer treatment with reduced systemic side effects.
How Transarterial Chemoembolization Works
During a TACE procedure, a catheter is inserted into the hepatic artery through a small incision in the groin. Using real-time imaging guidance, the catheter is advanced to the arteries supplying the tumor in the liver. Once in position, a chemotherapy drug or a combination of drugs mixed with a contrast agent is injected directly into the tumor-feeding arteries.
The chemotherapy drugs target the cancer cells, while the embolic agents, such as tiny beads, particles, or gelatin sponge, are then injected to block the blood flow to the tumor. By cutting off the blood supply, the embolic agents help trap the chemotherapy within the tumor, enhancing its effectiveness while minimizing exposure to healthy tissues.
Indications for Transarterial Chemoembolization
TACE is commonly recommended for patients with hepatocellular carcinoma who are not suitable candidates for surgery, either due to the size or location of the tumor, or because of underlying health conditions. It is often used as a palliative treatment to slow tumor growth, alleviate symptoms, and improve overall survival rates.
Benefits of Transarterial Chemoembolization
1.Localized Treatment: TACE delivers high concentrations of chemotherapy directly to the tumor site, maximizing its effectiveness while reducing systemic exposure and side effects.
2.Minimally Invasive: Compared to surgical interventions, TACE is minimally invasive and typically requires a shorter recovery time.
3.Repeatable Procedure: TACE can be repeated multiple times, allowing for ongoing tumor management and monitoring of treatment effectiveness.
4.Palliative Care: TACE can help improve quality of life by reducing tumor size, relieving symptoms, and potentially extending survival in patients with advanced liver cancer.
Risks and Considerations
While TACE is generally well-tolerated, there are some risks and considerations associated with the procedure, including:
• Post-embolization Syndrome: Patients may experience mild flu-like symptoms, such as fever, nausea, and pain, following the procedure.
• Liver Function: TACE can temporarily affect liver function, which is closely monitored by healthcare providers.
• Complications: Rare complications include damage to healthy liver tissue, infection, or blood vessel injury.
In the realm of hepatic artery interventions, the integration of advanced models for training and device development has become imperative. This model is meticulously crafted, featuring a detailed representation of key vascular components essential in hepatic interventions. From the femoral artery to the hepatic portal vein, each segment, including the celiac trunk and common hepatic artery, is intricately designed. The model is encased in a transparent acrylic tank, offering a comprehensive view of the intricate network of vessels.
Key elements such as the hepatic artery, hepatic vein, and hepatic portal vein are embedded within a transparent rigid liver model, providing a realistic simulation of the hepatic vascular system. Transparent acrylic supports elevate the remaining segments, enhancing spatial perception and facilitating a deeper understanding of anatomical relationships